MAPT and Alzheimer disease: Using the same methods tau oligomers appeared to constitute a minority (20%) of total tau species in the AD brain, consistent with the view that tau oligomers are structurally distinct from other tau species and raising the possibility that the oligomeric conformation(s) contributes to toxic properties (Lasagna-Reeves et al., 2012b).